• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 2 Company
  • 2.1 Philosophy
  • 2.2 Facts and Figures
  • 2.3 Management Board
  • 2.4 History
  • 2.5 Merz Pharmaceuticals
  • 2.6 Merz Consumer Care
  • 2.7 Merz Dental
  • 2.8 Merz Hygiene
  • 2.9 Merz Group
  • 2.10 Locations

Facts and Figures

Headquarters:	Frankfurt am Main, Germany
Branch Offices:	Germany, Great Britain, France, Italy, Spain, Switzerland, Austria, USA, Mexico, Russia
Joint Ventures:	Portugal
Status:	Private company
Fiscal Year:	July 1 - June 30

Key Figures of the Merz Group
		2006/07	2005/06	Change in %
Sales	EUR million	535,5	474,5	12,9
of which:
Pharmaceuticals	EUR million	359,4	305,6	17,6
Consumer Products	EUR million	110,9	103,6	7,0
Writing Instruments	EUR million	65,2	65,3	– 0,2
of which:
Germany	EUR million	184,4	171,7	7,4
Rest of Europe	EUR million	163,0	143,0	14,0
America	EUR million	177,8	148,5	19,7
Rest of world	EUR million	10,3	11,3	– 8,9
Performance
EBIT	EUR million	112,4	94,8	18,6
EBIT margin	%	21,0	20,0	–
Pre-tax profit	EUR million	115,4	97,8	18,0
Net profit	EUR million	70,0	58,0	20,7
Operating cash flow	EUR million	122,0	102,9	18,6
Research and development
Research and development expenses		60,1	50,6	18,8
of which: Pharmaceuticals		57,9	47,9	20,9
Financial position
Investments	EUR million	28,3	31,1	– 9,0
Depreciation and amortization	EUR million	9,9	7,8	26,9
Equity	EUR million	270,1	212,4	27,2
in % of balance sheet total	%	63,4	61,4	–
Balance sheet total	EUR million	426,0	346,0	23,1
Employees
Number of employees as of balance sheet date		2.052	1.915	7,0

Download Annual Report

Most Important Products of Merz Pharmaceuticals:

• Axura® (Alzheimer’s)
• PK-Merz® (Parkinson’s)
• Solvex® (depression)
• Contractubex® / Mederma® (scars)
• Naftin® (fungal diseases)
• Pantogar® / Pantovigar® (hair loss)
• Pantostin® (hair loss)
• Hyal-System® (wrinkles)
• Hepa-Merz® (liver-related brain impairment)
• Lipo-Merz retard® (lipid metabolism disorders)
• Xeomin® (Blepharospasm; cervical dystonia of a predominantly rotational form)

Most Important Consumer Care Brands:

• tetesept® (OTC drugs)
• Merz Spezial® (beauty care)

Shareholders´council:

• Dr. Jochen Hückmann

Merz Management Board (MMB):

• Dr. Martin Zügel, Chairman of the Management Board
• Hartmut Erlinghagen
• Dr. Matthias Vogt

Supervisory Board:

• Edward R. Roberts, Chairman
• Michael Freiherr von Truchseß, assistant Chairman
• Prof. Dr. Dr. h.c. Rolf Krebs
• Prof. Dr. Harald Wiedmann

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

Broschures

• Merz Annual Reports

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s